Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
March 22, 2017 7:34 AM EDTCantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More
Allscripts (MDRX) PT Raised to $13 at Cowen Following Investor Conference; 'Incrementally Positive'
March 22, 2017 6:09 AM EDTCowen analyst Charles Rhyee raised its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $12.00) while maintaining a Market Perform rating, suggesting an incrementally positive outlook on the company following the Investor Conference.
Rhyee comments, "Following the Investor Conference, we are incrementally... More
Allscripts (MDRX) volatility flat into investor day
March 20, 2017 8:52 AM EDTAllscripts (NASDAQ: MDRX) April call option implied volatility is at 30, May is at 31; compared to its 52-week range of 25 to 46 into a company hosted investor day on March 21.
... More